Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
4(80.0%)
Phase 1
1(20.0%)
5Total
N/A(4)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06443385Not ApplicableCompleted

E-mails to Nudge Safer and Better-Informed Prescribing of Risky Drugs

Role: collaborator

NCT06408662Not ApplicableRecruiting

Remote Delivery of a Mindfulness-based Intervention for Tics

Role: collaborator

NCT03771235Not ApplicableCompleted

Online Mindfulness-based Tic Reduction (Phase Two)

Role: lead

NCT03525626Not ApplicableCompleted

Online Mindfulness-based Tic Reduction

Role: lead

NCT01327027Phase 1Completed

Vasopressin Effects on Human Social Communication

Role: lead

All 5 trials loaded